Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
about
Megalin in acute kidney injury: foe and friendRecent insights into the biological functions of liver fatty acid binding protein 1Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesHeart-type fatty acid binding protein is associated with proteinuria in obesity.Distinct roles of urinary liver-type fatty acid-binding protein in non-diabetic patients with anemia.Comparison of three early biomarkers for acute kidney injury after cardiac surgery under cardiopulmonary bypassRenoprotective approaches and strategies in acute kidney injuryRole of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgeryClinical use of biomarkers for toxicant-induced acute kidney injury.Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury.Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?The impact of fluid balance on diagnosis, staging and prediction of mortality in critically ill patients with acute kidney injury.Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model.Vitamin E (α‑tocopherol) ameliorates aristolochic acid‑induced renal tubular epithelial cell death by attenuating oxidative stress and caspase‑3 activation.Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation.Clinical Usefulness of Urinary Liver Fatty Acid-Binding Protein Excretion for Predicting Acute Kidney Injury during the First 7 Days and the Short-Term Prognosis in Acute Heart Failure Patients with Non-Chronic Kidney Disease.Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.Kidney disease models: tools to identify mechanisms and potential therapeutic targets.Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.Evaluation of novel biomarkers in nephrotoxicity.Comparison of the effect of non-esterified and esterified astaxanthins on endurance performance in mice.
P2860
Q26823048-5C11A3F6-4B06-4D14-BD4C-931152BECD75Q28268205-1FE2822C-D24A-4541-9609-0A9D3113713DQ33838866-9E2147BC-E86C-4E10-8897-F47FFB3D81CFQ34429806-149E5B0F-5518-46AD-8465-8C9A8DDEBB08Q35641693-8F4769F8-59DF-480E-93CF-22A9EAEF0686Q37024526-A23DEB4F-38A9-48B3-9A43-FE0CB5099F88Q37441818-D6415ABA-9910-43AE-9574-0124A24C0744Q37510401-A34D50DC-9467-4024-B46B-795CF09589FEQ37736068-2DA4470B-ACA6-48CC-8B28-1CB1014CC18AQ38111809-42250333-408E-49C2-9F87-B194CF71F250Q38391570-9185C255-1BE7-4146-BC71-BDA437DCEAE9Q40827374-B6CBDDCA-30D5-4DDA-9E44-E7FFA3414538Q41209439-5FC0FF1E-0CBB-44FA-A787-DF3C13491C8AQ41716321-80E8B779-1A40-4691-A0EC-14828F6338A9Q41921400-B6FFFB1E-804A-42C5-8C49-0D5150D754D3Q46266046-3F2527C4-FC67-4109-A895-DD43FB804E5AQ46294638-8759CB43-8877-4CD0-8CA5-55CF74DB3431Q46945650-BB693D96-B5E4-40BA-AD8F-04CAA8C6E7A1Q47423221-97546758-D0E4-42E5-9B04-59B001E638E9Q50950531-B16988E2-A3A0-4315-A30E-1E995F12C953Q52668596-9B7B9F37-6EFA-4EF4-BC32-9CE5D7CA21D5Q53009256-5F7FBECB-7911-4B1B-AE87-D60578029F0DQ53648241-CB2AA91A-1948-418F-82A5-8DFE325CCAA2Q54964055-9D58C69D-08B4-4B56-B669-1CE1EEF2FAE2
P2860
Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@ast
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@en
Renal liver-type fatty acid binding protein
@nl
type
label
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@ast
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@en
Renal liver-type fatty acid binding protein
@nl
prefLabel
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@ast
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@en
Renal liver-type fatty acid binding protein
@nl
P2093
P2860
P1476
Renal liver-type fatty acid bi ...... stolochic acid nephrotoxicity.
@en
P2093
Atsuko Kamijo-Ikemorif
Katsuomi Matsui
Kenjiro Kimura
Takashi Yasuda
Takeshi Sugaya
P2860
P304
P356
10.1016/J.AJPATH.2010.12.002
P407
P577
2011-03-01T00:00:00Z